Wyo. Code R. 052-0001-6
Medicine, Board of
Chapter 6: Miscellaneous
Effective Date: 01/29/2003 to 07/14/2004
Rule Type: Superceded Rules & Regulations
Reference Number: 052.0001.6.01292003
(a) At each regularly scheduled meeting, the board shall review reports of malpractice claims against Wyoming licensed physicians reported since the last board meeting.
(b) Based on this review, the board shall determine if further review and/or investigation is necessary under the terms and provisions of the act. If further review and/or investigation is deemed necessary, the matter shall be handled as a board initiated complaint pursuant to chapters 4 and 5 of these rules.
(c) The executive secretary shall compile all reports of malpractice claims from licensees, insurance carriers, attorneys, courts, healthcare entities, data banks and other reliable sources and maintain statistics for each licensee as to the number, frequency, nature and disposition of such claims.
(a) Final disciplinary orders entered in other jurisdictions against Wyoming licensed physicians shall be handled as follows:
(i) Those with current Wyoming licenses who are practicing in Wyoming may be subject to a board initiated complaint and investigation pursuant to chapters 4 and 5 of these rules.
(ii) Those with current licenses but practicing out of state shall be served with a consent agreement requiring the physician to notify the board in writing at least thirty (30) days prior to returning to the state to practice. A physician's or physician assistant's failure or refusal to sign such agreement may initiate disciplinary proceedings against his/her license.
All final board orders subject to public disclosure pursuant to W.S. 33-26-408(c) shall be sent to any medical facilities where the licensee has privileges, to the appropriate state medical society and to any local county medical society to which the licensee might belong, to a wire service, to the Federation of State Medical Boards, to the National Practitioner Data Bank when applicable, to the Wyoming Board of Pharmacy and to the Federal Drug Enforcement Agency.
(a) For all purposes, the term 'board record' as set forth in W.S. 33-26-408(c) includes all information acquired by the board by any means except:
(i) The name of the licensee;
(ii) The licensure status of a licensee, i.e., current and in good standing, current with conditions or restrictions, lapsed, suspended, surrendered or revoked;
(iii) The professional designation of a licensee, i.e., M.D. or D.O.;
(iv) The licensee’s medical speciality;
(v) Whether the licensee is board certified and
(vi) The current practice address and current telephone number at such address of a licensee.
(b) All other information except that specifically described in subsection (a) maintained or in the possession of the members, employees or agents of the board, shall be considered a ‘board record’, including but not limited to documents, records, summaries, photographs, diplomas, correspondence, test scores and licensure verification, and shall not be available for public dissemination or disclosure except as required by W.S. 33-26-408(c).
(c) The Board may disseminate the information set forth in subsection (a) above by any means including, but not limited to, responses to inquiries, any Internet webpages maintained or contributed to by the Board and in the physician directory published annually by the Board.
(d) This definition shall not restrict the type or content of information that the Board is required to disclose pursuant to W.S. 33-26-202(b)(vii) or information, the disclosure of which has been waived by the licensee who is the subject of such information.